An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Elkahloun, Abdel G.
Saavedra, Juan M.
Funding for this research was provided by:
National Institutes of Health
Text and Data Mining valid from 2016-01-28
Version of Record valid from 2016-01-28
26 September 2015
8 December 2015
28 January 2016